Simvastatin cardioprotection in cyclophosphamide-induced toxicity via the modulation of inflammasome/caspase1/interleukin1β pathway

MLA

Marwa MM Refaie, et al. “Simvastatin Cardioprotection in Cyclophosphamide-Induced Toxicity via the Modulation of Inflammasome/Caspase1/Interleukin1β Pathway.” Human & Experimental Toxicology, vol. 41, Jan. 2022, p. 096032712211114. EBSCOhost, https://doi.org/10.1177/09603271221111440.

APA

Marwa MM Refaie, Maram El-Hussieny, Asmaa MA Bayoumi, Sayed Shehata, Nermeen N Welson, & Walaa Yehia Abdelzaher. (2022). Simvastatin cardioprotection in cyclophosphamide-induced toxicity via the modulation of inflammasome/caspase1/interleukin1β pathway. Human & Experimental Toxicology, 41, 096032712211114. https://doi.org/10.1177/09603271221111440

Chicago

Marwa MM Refaie, Maram El-Hussieny, Asmaa MA Bayoumi, Sayed Shehata, Nermeen N Welson, and Walaa Yehia Abdelzaher. 2022. “Simvastatin Cardioprotection in Cyclophosphamide-Induced Toxicity via the Modulation of Inflammasome/Caspase1/Interleukin1β Pathway.” Human & Experimental Toxicology 41 (January): 096032712211114. doi:10.1177/09603271221111440.